Published in Int J Obes (Lond) on May 05, 2009
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39
Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) (2009) 2.70
Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology (2011) 2.45
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22
Metabolic surgery for type 2 diabetes with BMI <35 kg/m(2) : an endocrinologist's perspective. Obes Surg (2013) 2.00
All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev (2012) 1.74
Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol (2009) 1.72
The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia (2010) 1.67
Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology (2010) 1.64
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab (2011) 1.63
Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg (2009) 1.56
Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med (2010) 1.54
Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery. Obes Surg (2012) 1.50
Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg (2011) 1.46
Hormonal responses and test meal intake among obese teenagers before and after laparoscopic adjustable gastric banding. Am J Clin Nutr (2013) 1.41
Roux-en-Y gastric bypass surgery changes food reward in rats. Int J Obes (Lond) (2010) 1.41
The effect of bariatric surgeries on nonalcoholic fatty liver disease. Saudi J Gastroenterol (2014) 1.39
Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients. Diabetes (2013) 1.37
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care (2011) 1.31
Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring) (2010) 1.29
Roux en Y gastric bypass increases ethanol intake in the rat. Obes Surg (2013) 1.25
Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond) (2013) 1.24
Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol (2013) 1.21
Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol Motil (2012) 1.18
GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol (2014) 1.16
Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg (2013) 1.15
Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss. Obesity (Silver Spring) (2011) 1.14
Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) (2010) 1.13
Obesity and appetite control. Exp Diabetes Res (2012) 1.05
Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism. PLoS One (2012) 1.04
Effect of vertical sleeve gastrectomy on food selection and satiation in rats. Am J Physiol Endocrinol Metab (2012) 1.04
Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents. Obesity (Silver Spring) (2010) 1.02
The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity. Physiol Behav (2010) 1.00
Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab (2014) 0.99
Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats. PLoS One (2013) 0.99
Neural responsivity to food cues in fasted and fed states pre and post gastric bypass surgery. Neurosci Res (2012) 0.98
Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res (2010) 0.97
Obesity surgery and gut-brain communication. Physiol Behav (2011) 0.97
Effects of bariatric surgery on food cravings: do food cravings and the consumption of craved foods "normalize" after surgery? Surg Obes Relat Dis (2011) 0.94
Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet. Mol Endocrinol (2013) 0.92
Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Best Pract Res Clin Gastroenterol (2014) 0.92
Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity (Silver Spring) (2013) 0.91
Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr (2011) 0.91
Gut microbial communities modulating brain development and function. Gut Microbes (2012) 0.90
Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Invest (2015) 0.90
Vagal innervation of the hepatic portal vein and liver is not necessary for Roux-en-Y gastric bypass surgery-induced hypophagia, weight loss, and hypermetabolism. Ann Surg (2012) 0.89
Integrating GHS into the Ghrelin System. Int J Pept (2010) 0.88
The gut hormones in appetite regulation. J Obes (2011) 0.88
Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis. Nat Rev Gastroenterol Hepatol (2012) 0.87
Ghrelin and metabolic surgery. Int J Pept (2010) 0.87
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? Int J Obes (Lond) (2013) 0.86
Randomized double-blind placebo-controlled study of leptin administration after gastric bypass. Obesity (Silver Spring) (2013) 0.86
Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review. Obes Surg (2016) 0.85
Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4. Endocrinology (2012) 0.85
Impact of bariatric surgery on ghrelin and obestatin levels in obesity or type 2 diabetes mellitus rat model. J Diabetes Res (2014) 0.85
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol (2014) 0.85
The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery. Curr Diab Rep (2014) 0.85
Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study. J Obes (2014) 0.84
Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol (2011) 0.84
Impact of Weight Loss Surgery on Esophageal Physiology. Gastroenterol Hepatol (N Y) (2015) 0.84
Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence. J Biomed Res (2014) 0.82
Bone loss after bariatric surgery: causes, consequences, and management. Lancet Diabetes Endocrinol (2014) 0.82
Roux-en-Y gastric bypass increases intravenous ethanol self-administration in dietary obese rats. PLoS One (2013) 0.81
Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats. Am J Physiol Endocrinol Metab (2012) 0.81
Serum leptin levels are inversely correlated with omental gene expression of adiponectin and markedly decreased after gastric bypass surgery. Surg Endosc (2011) 0.81
Can Bayliss and Starling gut hormones cure a worldwide pandemic? J Physiol (2014) 0.81
FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes. Obes Surg (2016) 0.81
Metabolic surgery-principles and current concepts. Langenbecks Arch Surg (2011) 0.80
Ghrelin and eating disorders. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.80
Molecular neuroendocrine targets for obesity therapy. Curr Opin Endocrinol Diabetes Obes (2010) 0.79
Impact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on ghrelin, obestatin, and ghrelin/obestatin ratio in morbidly obese patients. Obes Surg (2011) 0.79
Peripheral signals mediate the beneficial effects of gastric surgery in obesity. Gastroenterol Res Pract (2015) 0.78
Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes. Diabetol Metab Syndr (2015) 0.78
Gastric Bypass Surgery but not Caloric Restriction Improves Reproductive Function in Obese Mice. Obes Surg (2016) 0.78
Molecular insights from bariatric surgery. Rev Endocr Metab Disord (2011) 0.77
Recombinant human leptin does not alter gut hormone levels after gastric bypass but may attenuate sweet cravings. Int J Endocrinol (2014) 0.77
Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity. Surg Endosc (2015) 0.76
Implantable gastric stimulator does not prevent the increase in plasma ghrelin levels that occurs with weight loss. Obesity (Silver Spring) (2011) 0.76
Role of gastrointestinal hormones in feeding behavior and obesity treatment. J Gastroenterol (2015) 0.75
Physiology of weight loss surgery. Surg Clin North Am (2011) 0.75
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity. World J Diabetes (2016) 0.75
The Obese Brain--Effects of Bariatric Surgery on Energy Balance Neurocircuitry. Curr Atheroscler Rep (2015) 0.75
Insulinoma After Bariatric Surgery: Diagnostic Dilemma and Therapeutic Approaches. Obes Surg (2016) 0.75
Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity. Minerva Endocrinol (2015) 0.75
Effect of bariatric surgery on humoral control of metabolic derangements in obese patients with type 2 diabetes mellitus: How it works. World J Clin Cases (2015) 0.75
Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery. Pituitary (2012) 0.75
Peripheral Pathways in the Food-Intake Control towards the Adipose-Intestinal Missing Link. Int J Endocrinol (2013) 0.75
The role of hormonal factors in weight loss and recidivism after bariatric surgery. Gastroenterol Res Pract (2013) 0.75
Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol (2017) 0.75
The gut in the brain: the effects of bariatric surgery on alcohol consumption. Addict Biol (2016) 0.75
The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events. Front Endocrinol (Lausanne) (2017) 0.75
Potential Hormone Mechanisms of Bariatric Surgery. Curr Obes Rep (2017) 0.75
Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding. ISME J (2017) 0.75
Effects of Roux-en-Y operations on glucose homeostasis in obese GK rats. Surg Endosc (2011) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med (2002) 9.91
The physiology of glucagon-like peptide 1. Physiol Rev (2007) 9.07
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19
Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA (2002) 3.75
Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02
Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab (2004) 3.01
Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis (2007) 3.01
Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab (2004) 2.71
The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest (2003) 2.42
Surgery for severe obesity. N Engl J Med (2004) 2.34
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction. Int J Obes Relat Metab Disord (2001) 2.05
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes (2007) 1.96
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg (2006) 1.91
Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg (1990) 1.90
Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) (2006) 1.69
Insulin and leptin as adiposity signals. Recent Prog Horm Res (2004) 1.60
Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology (2003) 1.36
Thyroid hormones and their relation to weight status. Horm Res (2008) 1.28
Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg (2007) 1.21
Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis (2007) 1.17
Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab (2005) 1.13
The central melanocortin system and the regulation of energy balance. Front Biosci (2007) 1.11
Changes in gut hormones after bariatric surgery. Clin Endocrinol (Oxf) (2007) 1.09
Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res (2004) 1.06
Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab (2007) 1.06
Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg (2008) 1.06
Leptin in the human stomach. Gut (2001) 1.05
Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg (2008) 1.04
Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab (2000) 1.01
Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest (2000) 0.99
Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg (2007) 0.98
The role of peptide YY in regulating glucose homeostasis. Peptides (2007) 0.92
Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab (2004) 0.91
Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Nat Clin Pract Gastroenterol Hepatol (2008) 0.89
Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass. Int J Obes Relat Metab Disord (1993) 0.89
High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab (2005) 0.89
Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controls. Int J Body Compos Res (2008) 0.87
Glucagon-like peptide 1: continued advances, new targets and expanding promise as a model therapeutic. Curr Opin Endocrinol Diabetes Obes (2007) 0.86
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (2001) 7.95
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med (1997) 3.91
Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med (1995) 3.60
Esophageal dilation after laparoscopic adjustable gastric banding. Surg Endosc (2007) 3.27
Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch Surg (1995) 2.79
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet (1996) 2.72
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab (2000) 2.14
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology (2008) 1.89
Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest (1997) 1.86
Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract (2001) 1.81
Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab (1995) 1.79
Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance. Curr Mol Med (2005) 1.78
Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int (2010) 1.74
The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab (2008) 1.67
The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol (1981) 1.61
Biochemistry, genetics, and applications of exopolysaccharide production in Streptococcus thermophilus: a review. J Dairy Sci (2003) 1.60
Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem (2007) 1.60
Neuropsychometric changes in patients after carotid endarterectomy. Stroke (1998) 1.57
Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. J Neuroendocrinol (2001) 1.56
Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell (1997) 1.54
Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab (2007) 1.53
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int (2009) 1.52
Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene. Blood (1999) 1.46
Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med (2000) 1.40
Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor. J Virol (1999) 1.36
The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol (1992) 1.29
Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans. Surg Endosc (2003) 1.28
Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab (2009) 1.26
Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab (1993) 1.25
Postoperative immune function varies inversely with the degree of surgical trauma in a murine model. Surg Endosc (1997) 1.25
Osteolysis after Charnley primary low-friction arthroplasty. A comparison of two matched paired groups. J Bone Joint Surg Br (1998) 1.23
Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg (1994) 1.21
Spontaneous pneumomediastinum. Am J Surg (1976) 1.20
X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation. Proc Natl Acad Sci U S A (1999) 1.12
Prostate-specific antigen density: a new prognostic indicator for prostate cancer. Int J Radiat Oncol Biol Phys (1993) 1.11
Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (1993) 1.11
Severe pain confounds neuropsychological test performance. J Clin Exp Neuropsychol (2000) 1.10
Yet another machine fault. Anesthesiology (1983) 1.09
Telomere associations in interphase nuclei: possible role in maintenance of interphase chromosome topology. J Cell Sci (2001) 1.08
FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med (2001) 1.08
Cardiac structure and diastolic function in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2010) 1.08
Role of Streptococcus thermophilus MR-1C capsular exopolysaccharide in cheese moisture retention. Appl Environ Microbiol (1998) 1.06
Genetic diversity and relationships among Venezuelan equine encephalitis virus field isolates from Colombia and Venezuela. Am J Trop Med Hyg (2001) 1.05
Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol (Oxf) (2008) 1.05
Increased tumor establishment and growth after open vs laparoscopic surgery in mice may be related to differences in postoperative T-cell function. Surg Endosc (1999) 1.04
Better preservation of immune function after laparoscopic-assisted vs. open bowel resection in a murine model. Dis Colon Rectum (1996) 1.04
Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos Int (2010) 1.03
Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density. Osteoporos Int (2011) 1.03
The effects of elevated intraabdominal pressure, hypercarbia, and positioning on the hemodynamic responses to laparoscopic colectomy in pigs. Surg Endosc (1998) 1.02
Abnormal visual pathways in human albinos studied with visually evoked potentials. Exp Neurol (1979) 1.02
Comparison of simple measures of insulin sensitivity in young girls with premature adrenarche: the fasting glucose to insulin ratio may be a simple and useful measure. J Clin Endocrinol Metab (2001) 1.02
Tumor growth after laparotomy or laparoscopy. A preliminary study. Surg Endosc (1995) 1.00
Progesterone modulation of alpha5 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes Brain Behav (2009) 1.00
The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis (1998) 1.00
Traumatic handling of the tumor independent of pneumoperitoneum increases port site implantation rate of colon cancer in a murine model. Surg Endosc (1998) 0.99
Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia (2002) 0.99
Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab (1997) 0.99
p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex. Oncogene (2011) 0.98
Development and characterization of lactose-positive pediococcus species for milk fermentation. Appl Environ Microbiol (1996) 0.98
Preservation of immune response after laparoscopy. Surg Endosc (1994) 0.97
Port site tumor recurrence rates in a murine model of laparoscopic splenectomy decreased with increased experience. Surg Endosc (2000) 0.96
Aortic balloon control of a traumatic aortoenteric fistula after damage control laparotomy: a case report. J Trauma (1996) 0.96
Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy. Neuroendocrinology (1992) 0.96
The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol (1996) 0.96
Helium-neon laser irradiation at fluences of 1, 2, and 4 J/cm2 failed to accelerate wound healing as assessed by both wound contracture rate and tensile strength. Lasers Surg Med (1997) 0.95
Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol (2001) 0.95
Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoene. Biochim Biophys Acta (1991) 0.94
Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis. Osteoporos Int (2007) 0.94
Reduced fracture risk with early corticosteroid withdrawal after kidney transplant. Am J Transplant (2011) 0.94
Survival of Lactobacillus acidophilus and Bifidobacterium bifidum in ice cream for use as a probiotic food. J Dairy Sci (1992) 0.94
Field studies on the epidemiology of Venezuelan hemorrhagic fever: implication of the cotton rat Sigmodon alstoni as the probable rodent reservoir. Am J Trop Med Hyg (1993) 0.94
Role of protein and lactose interactions in the age gelation of ultra-high temperature processed concentrated skim milk. J Dairy Sci (1993) 0.92
Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype. Blood (1993) 0.92
IgD-receptor-positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines. J Immunol (1990) 0.92
Increased tumor establishment and growth after open vs laparoscopic bowel resection in mice. Surg Endosc (1998) 0.91
Color of low-fat cheese influences flavor perception and consumer liking. J Dairy Sci (2012) 0.91
Influence of capsular and ropy exopolysaccharide-producing Streptococcus thermophilus on Mozzarella cheese and cheese whey. J Dairy Sci (2000) 0.91
Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism. J Clin Endocrinol Metab (2010) 0.90
Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood (1995) 0.90
Spatial dispersion of adult mosquitoes (Diptera: Culicidae) in a sylvatic focus of Venezuelan equine encephalitis virus. J Med Entomol (2001) 0.90
Reliability of testing measures in Duchenne or Becker muscular dystrophy. Arch Phys Med Rehabil (1991) 0.90
Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc (2005) 0.90
Increased rates of pulmonary metastases following sham laparotomy compared to CO2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine. Surg Endosc (2002) 0.90
General oncologic effects of the laparoscopic surgical approach. 1997 Frankfurt international meeting of animal laparoscopic researchers. Surg Endosc (1998) 0.89
Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant (1998) 0.89
Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women. Osteoporos Int (2010) 0.89
Myelodysplasia in a patient with pre-existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating from within a clonal disease. Br J Haematol (1994) 0.88
Effects of leptin receptor mutation on Agrp gene expression in fed and fasted lean and obese (LA/N-faf) rats. Endocrinology (2000) 0.88
Paroxysmal nocturnal hemoglobinuria: correction of abnormal phenotype by somatic cell hybridization. Somat Cell Mol Genet (1993) 0.88
New somatic mutation in the PIG-A gene emerges at relapse of paroxysmal nocturnal hemoglobinuria. Blood (1998) 0.88
Contrast agents for diagnostic ultrasound: development and evaluation of polymer-coated microbubbles. Biomaterials (1990) 0.87
Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults. Diabetes Obes Metab (2011) 0.87
Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Pediatr Endocrinol Metab (2000) 0.87
Volumetric bone mineral density at the spine and hip in Chinese American and White women. Osteoporos Int (2011) 0.87
Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controls. Int J Body Compos Res (2008) 0.87